pharmaphorum

Update: MSD's $9.2bn deal for flu biotech Cidara confirmed

MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a preventive antibody-based therapy for influenza. The agreement – first ...
pharmaphorum

MSD adds new indication for Welireg in rare tumours

MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...
IEEE

Realization of a 2-V Programmable Josephson Junction Array Using Balanced Segmentation Scheme

Abstract: This article proposes a balanced segmentation scheme to improve the microwave transmission and develops a 2-V programmable Josephson junction array using double-stacked superconductor-normal ...
Rochester Institute of Technology

Writing Instruction Workshops for Faculty - Workshop 2: Grading for Growth with AI

Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share via Email ...
Saudi Press Agency

Dammam Pharma, MSD Sign Agreement to Manufacture Type 2 Diabetes Medications in KSA

Riyadh, November 19, 2023, SPA -- An agreement was signed today at the Ministry of Industry and Mineral Resources between Dammam Pharma, 85% owned by Spimaco, and MSD to manufacture type 2 diabetes ...